Where does Nymox Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nymox Corporation ranks #21,542 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nymox Corporation hold?

Nymox Corporation holds 13 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Nymox Corporation's Innovation Score?

Nymox Corporation has an Innovation Score of 32.9 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nymox Corporation focus on?

Nymox Corporation's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 13 patents, ranking #1,747 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Nymox Corporation's patent grant rate increasing or decreasing?

Nymox Corporation's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nymox Corporation's patents?

Nymox Corporation's patents average 13.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nymox Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nymox Corporation

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nymox ranks #21,542 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#21,542
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (32.9/100): 13.2
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21542 · Foreign Corporation #21,542 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,542/49,997
PHOTO-FINISH Nanhu Laboratory
CPC-NARROW A61K · 5 areas
INNOV-THIN 32.9/100
CLAIMS-RICH 13.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nanhu Laboratory (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nymox’s 32.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (28%) Velocity 8.0 pts (24%) Breadth 7.9 pts (24%) Claim depth 7.9 pts (24%)

Qualcomm Incorporated · highest

85
Nymox · this assignee

33
3D Lighting… · lowest

7

What this shows Nymox's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nymox?

Each dot is one of Nymox’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nymox’s own 13.2 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nymox vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nymox's grants concentrate

Nymox Corporation is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2016. By volume, Nymox sits between Noroo BEE Chemical Co., Ltd. and Natel Energy Holdings, Inc..

Nymox's three-year grant acceleration

Nymox Corporation shows 6 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Noroo BEE Chemical

13
Northwest Institu…

13
NPL Management

13
Nucap Industries

13
Nanhu Laboratory

13
Nanocav

13
Nashville Wire Pr…

13
Natel Energy Hold…

13
Nymox ◀

13

What this shows Nymox holds 13 patents at rank #21,515, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nymox

By rank, the assignees closest to #21,515 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Nymox's primary technology class.

Nymox's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Nymox Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	7.7%
2019	3	23.1%
2020	2	15.4%
2022	4	30.8%
2023	1	7.7%
2024	1	7.7%
2025partial year	1	7.7%

Which technologies does Nymox Corporation patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C07K - Peptides 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nymox Corporation's patent record in context - here's where to go next.

Nymox Corporation's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #21,542 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nymox Corporation against Noroo BEE Chemical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.